- Atogepant (Qulipta): Migraine, Dosage, Side Effects - Drugs. com
Atogepant is a prescription medicine used to help prevent migraine headaches, including episodic and chronic migraines, in adults Atogepant's brand name is Qulipta by AbbVie Inc , and is a tablet that is taken once a day
- Atogepant - Wikipedia
Atogepant, sold under the brand name Qulipta among others, is a medication used to prevent migraines [4][5] It is a gepant, a calcitonin gene-related peptide receptor antagonist administered orally [4][7] The most common side effects include nausea, constipation, tiredness, somnolence (sleepiness), decreased appetite, and decreased weight [5]
- Atogepant (oral route) - Side effects dosage
Headaches that are not relieved by atogepant are sometimes caused by conditions that need other treatment This medicine comes with a patient information leaflet Read and follow these instructions carefully Ask your doctor if you have any questions You may take this medicine with or without food
- QULIPTA® (atogepant) for Migraine Prevention
Discover QULIPTA® (atogepant), a pill specifically designed to prevent migraine attacks in adults See full Patient and Safety Information
- Atogepant: MedlinePlus Drug Information
Atogepant is used to prevent migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light) Atogepant is in a class of medications called calcitonin gene-related peptide receptor antagonists
- Atogepant for the Preventive Treatment of Migraine
Atogepant is an oral, small-molecule, calcitonin gene–related peptide receptor antagonist that is being investigated for the preventive treatment of migraine
- Qulipta (atogepant): Uses, Side Effects, Interactions, Pictures . . . - WebMD
Find patient medical information for Qulipta (atogepant) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Atogepant: Mechanism of action, clinical and translational science
In this article, we summarize the role of CGRP in migraine pathophysiology and the mechanism of action of atogepant In addition, we provide an overview of atogepant's pharmacology and the key clinical trials and outcomes that have demonstrated the safety and efficacy of atogepant
|